Potential vaccines and post-exposure treatments for filovirus infections. - Test2 - elhamkhani - TriplyDB

Potential vaccines and post-exposure treatments for filovirus infections.

Potential vaccines and post-exposure treatments for filovirus infections.

http://www.wikidata.org/entity/Q36404178

about

Animal models for Ebola and Marburg virus infections Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb Ebola virus disease and critical illness.Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment.Three minimal sequences found in Ebola virus genomes and absent from human DNA.Ebolavirus in West Africa, and the use of experimental therapies or vaccines.Post-exposure treatment of Ebola virus disease in guinea pigs using EBOTAb, an ovine antibody-based therapeutic.Human monoclonal antibodies as candidate therapeutics against emerging viruses and HIV-1.Development of Small-Molecule Antivirals for Ebola.Vesicular stomatitis virus pseudotyped with Ebola virus glycoprotein serves as a protective, non-infectious vaccine against Ebola virus challenge in mice.Ebola Virus Makona Shows Reduced Lethality in an Immune-deficient Mouse Model.Experimental Respiratory Infection of Marmosets (Callithrix jacchus) With Ebola Virus Kikwit.A novel mechanism of immune evasion mediated by Ebola virus soluble glycoprotein.Distinct Immunogenicity and Efficacy of Poxvirus-based Vaccine Candidates against Ebola Virus expressing GP and VP40 Proteins.

P2860

Q21131118-1024FF24-B757-4C7B-A5A7-2373C9818906 Q24594601-9BB973A9-855F-4350-ABEE-2B46BFA65312 Q26250274-FDDA1945-5D17-46C1-9757-78D66F0AF8A2 Q34464824-46020EC1-3E81-45EA-A876-5EAEFC1170C4 Q34470151-806A3D41-3B11-43A0-9EA8-02D0B51080C4 Q35305323-38693968-8657-4416-B66D-C356A98E8596 Q37134982-3350218D-FF5F-403D-80D6-2F1A8900DA1A Q38098075-171FFF56-DA05-40D0-AA34-B98172B6ABE1 Q38546746-D7534959-A64B-4DA9-B8D9-E12CC711AC32 Q40052567-AAF15BC9-7A46-4A5F-8164-F0F158B61208 Q40094833-6ECD90D9-7946-4F02-B2C2-0CAE2B0E924A Q40145853-8F4BAACB-77FC-4741-8658-E457C362CDC0 Q40249528-53ECC531-6C14-4E9E-A13B-3E5742377C3D Q51784219-34168314-6BD4-43F3-A11A-C218BB66D4EC

P2860

Potential vaccines and post-exposure treatments for filovirus infections.

http://www.wikidata.org/entity/Q36404178

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Potential vaccines and post-exposure treatments for filovirus infections.

@ast

Potential vaccines and post-exposure treatments for filovirus infections.

@en

type

label

Potential vaccines and post-exposure treatments for filovirus infections.

@ast

Potential vaccines and post-exposure treatments for filovirus infections.

@en

prefLabel

Potential vaccines and post-exposure treatments for filovirus infections.

@ast

Potential vaccines and post-exposure treatments for filovirus infections.

@en

P1433

Q36404178-F4E6FB23-5D20-4ED4-89E2-4F49C97C22C5

P1476

Q36404178-88CBE330-BA22-4798-8C46-A9CF2C178014

P2093

Q36404178-7DDE9FFD-F544-4D26-89DC-1E86D91CD73F

Q36404178-A1CC46D9-DDAC-4CD1-B15D-064670D25E23

Q36404178-E44DF421-6959-4D21-9F17-5E26493DEC97

Q36404178-F9B7029B-D04D-42D6-BF0D-9AC4647834D3

P275

Q36404178-2C624643-5014-4384-AEFD-5E9DA1A53E5E

P2860

Q36404178-012EF29D-E895-4FF8-A064-09B029C51F22

Q36404178-033B188D-7E41-4C4F-AF1C-7DA3D2ACA3A1

Q36404178-0440AC30-9944-4A7F-AEED-B5C9E6A52025

Q36404178-05C8F945-24DD-4680-B2C8-F8961233F2B4

Q36404178-067927D5-B536-446D-AFF1-DCCE3640B266

Q36404178-070F8F7B-AE9B-4720-9C8E-FEE92A7C1641

Q36404178-07FF4E70-B270-4A14-9361-090F4C8A8420

Q36404178-08674898-78B1-48E1-950F-F1E14DC08228

Q36404178-08A2B2EC-A612-482D-8233-EE11AE031C8C

Q36404178-0946D5F5-4CCF-49EA-B9A0-0CEA24CB57D5

P304

Q36404178-59B544F1-18F5-42A0-9B19-30DD17E44E54

P31

Q36404178-561EC531-D739-461B-BF21-41574D9D7E41

Q36404178-A695D049-BEEF-454A-B103-5EAB5469C383

P356

Q36404178-4ED8DA81-391A-44A5-B866-86886AD434A5

P433

Q36404178-12F9CBD7-81B3-49C3-84D2-09394D5CD1D8

P478

Q36404178-7AA9248E-BFC8-4382-9E1F-76F1B0F70435

P50

Q36404178-52AB12A6-6D31-4B57-872B-9E85DA2DB3BF

Q36404178-5D9291FF-F652-4E0B-AB65-2CACA60160D7

Q36404178-93BF8C25-F5DE-4E3C-A671-0AB69F660F2D

P577

Q36404178-48F5E407-4A9F-4B0B-86BC-A57068A0A2A6

Q36404178-ACA78CF1-DA70-4F2C-A107-769FB4D35BB0

P5875

Q36404178-2C9936B1-1323-421A-BE9A-E2E2135A32D4

P698

Q36404178-56D63F71-A36C-43C9-B61A-4E70FF1A98BC

P921

Q36404178-2FA44A99-6965-4523-A6F5-0101B7A324BE

Q36404178-D4B24D02-8DC1-4339-B524-E60D3C2664C1

P932

Q36404178-9377DAE1-5BBC-4AE2-9491-33B444E35935

P356

P1433

P1476

Potential vaccines and post-exposure treatments for filovirus infections.

@en

P2093

Brian M Friedrich

http://www.w3.org/2001/XMLSchema#string

Darci R Smith

http://www.w3.org/2001/XMLSchema#string

John C Trefry

http://www.w3.org/2001/XMLSchema#string

Julia E Biggins

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Marburg virus infection detected in a common African bat

Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates

Recovery potential of a western lowland gorilla population following a major Ebola outbreak: results from a ten year study.

Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates

Effective post-exposure treatment of Ebola infection

Large serological survey showing cocirculation of Ebola and Marburg viruses in Gabonese bat populations, and a high seroprevalence of both viruses in Rousettus aegyptiacus

Recent advances in Ebolavirus vaccine development

T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus

Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis

Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection

P304

1619-1650

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/V4091619

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2012-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233739040

http://www.w3.org/2001/XMLSchema#string

P698

23170176

http://www.w3.org/2001/XMLSchema#string

P921

preventive health services

P932

3499823

http://www.w3.org/2001/XMLSchema#string